Global Point of Care Glucose Testing (POCGT) Market Size Hit USD 4.58 Billion at a CAGR of 4% in 2032

The global Point of Care Glucose Testing (POCGT) market size was USD 3.22 Billion in 2022 and is expected to register a revenue CAGR of 4% over the forecast period, according to the latest report by Reports and Data.

The prevalence of diabetes, particularly Type 2, is increasing, making POCGT increasingly necessary. The International Diabetes Federation estimates that 10.4% of people worldwide had diabetes in 2021, and this number is expected to rise to 11.4% by 2045. This growth is attributed to more people adopting unhealthy lifestyles that include sedentary behaviour, poor diets, and insufficient exercise. Patients with diabetes require real-time and accurate glucose monitoring to manage their condition effectively, leading to an anticipated rise in demand for POCGT.

Technological advancements such as wireless connectivity, miniaturization, and cloud computing have made POCGT devices more precise, practical, and cost-effective. In addition, the integration of Continuous Glucose Monitoring (CGM) devices and the utilization of Artificial Intelligence (AI) and Machine Learning (ML) algorithms have substantially enhanced the accuracy and effectiveness of glucose monitoring.

Some of the prominent players in the global Point of Care Glucose Testing (POCGT) Market include Lonza Group AG, Boehringer Ingelheim GmbH, Samsung Biologics Co. Ltd., Thermo Fisher Scientific Inc., Fujifilm Diosynth Biotechnologies, Catalent, Inc., Wuxi Biologics, AbbVie Inc., Cytiva (Danaher Corporation), and AGC Biologics.

Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/5987

Market Overview:

The research report assesses the market dynamics, market landscape, company profiles, production and manufacturing capacity, year-on-year growth rate, SWOT analysis, and Porter’s Five Forces analysis. The report estimates the market size, market growth, and provides an accurate forecast for the key segments of the market for the forecast period of 2022-2032. The report also covers an in-depth analysis of the key competitors of the market, along with their growth strategies and business expansion plans.

The Point of Care Glucose Testing (POCGT) Market has been segmented into key regions of the world and offers an analysis of growth rate, market share, market size, current and emerging trends, production and consumption ratio, industrial chain analysis, demand and supply, import and export, revenue contribution, and presence of key players in each region. A country-wise analysis of the market is offered in the report to gain a better understanding of the regional spread and progress of the Point of Care Glucose Testing (POCGT) Market.

Further key findings from the report suggest,

• During the forecast period, the category of Accu Check Aviva Meters is predicted to have the highest revenue contribution. This is primarily due to the fact that the meter is a convenient choice for individuals who require frequent blood glucose monitoring, owing to its user-friendly design, easy-to-read display, and compact size. Additionally, the accuracy of the results provided by this meter is of great importance in the treatment of diabetes.
• The North American market is expected to have the highest revenue share in the foreseeable future due to the rise in deployment of POCGT devices, increasing diabetes prevalence, and growing awareness about the disease. Moreover, government initiatives aimed at promoting diabetes treatment and an aging population are also contributing to the market’s growth.
• Some of the prominent players profiled in the global POCGT market include Abbott Laboratories, Roche Diagnostics, Danaher Corporation, Siemens Healthcare, Nova Biomedical, Becton, Dickinson and Company, Bayer Healthcare, ARKRAY, Inc., Trividia Health, Inc., and Ascensia Diabetes Care Holdings AG.
• On June 15, 2020, Abbott Laboratories received FDA authorization for its FreeStyle Libre 2 iCGM system. This device offers continuous glucose monitoring without requiring fingerstick calibrations, and it utilizes a small sensor attached to the upper arm to provide glucose readings every minute. By improving diabetes control, this gadget has the potential to be very beneficial.
• In March 2020, Danaher Corporation acquired GE Biopharma, a leading provider of bioprocessing systems. This acquisition enabled Danaher’s bio sciences division to expand, specifically in the area of point of care testing solutions. As a result of the purchase, the division experienced significant growth.
• On December 10th, 2019, Roche Diagnostics launched the Accu-Chek SugarView application. This app provides personalized guidance and recommendations to individuals with diabetes, based on their blood glucose readings. Additionally, the app includes tools such as a food diary, an activity monitor, and other features to assist users in managing their diabetes.

To understand how our Point of Care Glucose Testing (POCGT) Market can bring difference to your business strategy:– https://www.reportsanddata.com/report-detail/point-of-care-glucose-testing-pocgt-market

• For the purpose of this report, Reports and Data has segmented the global POCGT market on the basis of Product Outlook, End Use Outlook, and Regional Outlook:

Product Outlook (Revenue, USD Billion; 2022 – 2032)

• Accu Check Aviva Meter
• Onetouch Verio Flex
• i-STAT
• Freestyle Lite
• Bayer CONTOUR Blood Glucose Monitoring System
• True Matrix
• Accu-Chek Inform II
• StatStrip
• Others

End Use Outlook (Revenue, USD Billion; 2022 – 2032)

• Hospital
• Home setting
• Diagnostic center

Regional Outlook (Revenue, USD Billion; 2019-2032)

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Sweden
  • BENELUX
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Rest of LATAM
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Israel
  • Rest of MEA

Request a customization of the report : https://www.reportsanddata.com/request-customization-form/5987

 Key Advantages of Point of Care Glucose Testing (POCGT) Market Report:

• Identification and analysis of the market size and competition
• Qualitative and quantitative analysis of the market data
• Data validated by industry experts after extensive primary and secondary research
• Extensive regional analysis of the Point of Care Glucose Testing (POCGT) industry
• Profiling of key players along with their business overview, business strategies, deals and partnerships, and product portfolio
• SWOT and Porter’s Five Forces Analysis for in-depth understanding of the competitive landscape
• Feasibility analysis and investment analysis to enable strategic investment decisions
• Analysis of opportunities, drivers, restraints, challenges, risks, and limitations

Conclusively, all aspects of the Point of Care Glucose Testing (POCGT) Market are quantitatively as well qualitatively assessed to study the global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects.

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com
Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports
Visit our blog for more industry updates @ https://www.reportsanddata.com/blogs

Image Credit

Browse More Reports:

https://www.biospace.com/article/transfer-membrane-market-size-to-reach-usd-204-75-million-in-2028-noted-reports-and-data/

https://www.biospace.com/article/nuclear-imaging-equipment-market-size-to-reach-usd-3-5-billion-in-2028-says-reports-and-data/

https://www.biospace.com/article/capillary-blood-collection-market-size-to-value-at-usd-2-10-billion-in-2028/

https://www.biospace.com/article/lung-in-vitro-market-size-to-reach-usd-976-9-million-in-2028-says-reports-and-data/

https://www.biospace.com/article/organs-on-chips-market-size-to-value-at-usd-294-75-million-in-2028-says-reports-and-data/

The post Global Point of Care Glucose Testing (POCGT) Market Size Hit USD 4.58 Billion at a CAGR of 4% in 2032 appeared first on Market O Graphics.